Rosella Mechelli Selected Research

Biomarkers (Surrogate Marker)

10/2022	Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.
5/2021	MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases.
1/2021	Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study.
1/2019	DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease.
1/2019	The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosella Mechelli Research Topics

Disease

19	Multiple Sclerosis 05/2021 - 12/2010
3	Huntington Disease (Huntington's Disease) 10/2022 - 01/2019
3	Relapsing-Remitting Multiple Sclerosis 01/2021 - 03/2014
2	Vitamin D Deficiency 01/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Neuroinflammatory Diseases 01/2017 - 05/2015
1	Rare Diseases (Rare Disease) 02/2024
1	Latent Infection 01/2022
1	Dysbiosis 05/2021
1	Disease Progression 01/2020
1	COVID-19 01/2020
1	Genetic Risk Score 01/2020
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2016
1	Low Vision (Subnormal Vision) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2013
1	Dianzani autoimmune lymphoproliferative syndrome 05/2012
1	Autoimmune Lymphoproliferative Syndrome 05/2012
1	Rheumatoid Arthritis 02/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
5	InterferonsIBA 01/2019 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2011
3	Interferon Type IIBA 01/2020 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015 - 01/2013
2	AntigensIBA 07/2013 - 01/2013
1	Small Nucleolar RNA (snoRNA)IBA 10/2022
1	Dimethyl FumarateIBA 01/2021
1	EdaravoneIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Interferon beta-1b (Betaseron)FDA Link 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	NitrogenIBA 01/2016
1	NitritesIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	3-nitrotyrosineIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	NitratesIBA 01/2016
1	Reactive Nitrogen SpeciesIBA 01/2016
1	VaccinesIBA 05/2015
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 03/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	CytokinesIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Interleukin-17 (Interleukin 17)IBA 03/2014
1	ChemokinesIBA 03/2014
1	CaspasesIBA 07/2013
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2013
1	Death Domain ReceptorsIBA 05/2012
1	Protein-Arginine DeiminasesIBA 03/2012
1	HLA-A Antigens (HLA-A)IBA 07/2011
1	NK Cell Lectin-Like Receptor Subfamily BIBA 02/2011
1	Antiviral Agents (Antivirals)IBA 12/2010

Therapy/Procedure

5	Therapeutics 02/2024 - 07/2013
1	Ligation 03/2014